Ex Parte Chandrasekaran - Page 4

               Appeal 2006-0959                                                                             
               Application 10/075,914                                                                       

               reasons advanced by the Examiner and provide the following discussion                        
               primarily for emphasis.                                                                      
               A. Rejection under 35 USC § 102(b)                                                           
                      The Examiner maintains two grounds of rejection over 35 U.S.C.                        
               § 102(b).  We discuss each separately as follows.                                            
                      1. Rejection of claims 1-10, 13, 15, 18, 20-22, 25, and 27 over                       
                            Ragheb.                                                                         
                      In rejecting claims 1-10, 13, 15, 18, 20-22, 25, and 27 over Ragheb,                  
               the Examiner finds that Ragheb describes an intraluminal stent including a                   
               biodegradable polymeric material covering a metallic reinforcing component                   
               as required by the first two clauses of claim 1.  With respect to the third                  
               clause of claim 1, the Examiner interprets this clause as encompassing the                   
               stent of Ragheb because neither “[t]he specification nor the claims provide                  
               specific structural limitations that distinguish the claimed invention from the              
               prior art.” (Answer, p. 7).  The Examiner provides two reasons why the                       
               language is not particularly limiting on the structure of the stent: (1) the                 
               sufficiency of the metallic reinforcing component in providing structural                    
               reinforcement is dependent on many factors including the size and shape of                   
               the lumen into which it is implanted; and (2) because the phrase                             
               “maintaining patency” encompasses maintaining the stent open by                              
               preventing endothelial cell growth or accumulation debris in the lumen as                    
               well as by preventing collapse of the stent structure (Id.).                                 
                      Appellant does not dispute that, as found by the Examiner, Ragheb                     
               describes an intraluminal stent including a metallic reinforcing component                   
               covered by a biodegradable polymeric material as required by the first two                   
               clauses of claim 1.  In fact, Appellant acknowledges that such stents were                   
                                                     4                                                      



Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007